A method for predicting the risk of getting a major adverse cardiac event
AssigneeSphingotec GmbH
InventorsAndreas BERGMANN, Leong NG
Life of this patent
Estimating the term…
Abstract
Disclosed is a method for predicting the risk of getting a major adverse cardiac event or death in a subject that has suffered an acute myocardial infarction containing determining the level of Protachykinin or fragments thereof of at least 5 amino acids in a bodily fluid obtained from the subject; and correlating the level of Protachykininor fragments thereof with the a risk for getting a major adverse cardiac event or death, wherein an elevated level is predictive for an enhanced risk of getting a major adverse cardiac event or death.
Claims14
A method for predicting the risk of getting a major adverse cardiac event or death in a subject that has suffered an acute myocardial infarction comprising:
- determining the level of Protachykinin or fragments thereof of at least 5 amino acids or Protachykinin comprising peptides in a bodily fluid obtained from said subject;
- and
- correlating said level of Protachykinin or fragments thereof or Protachykinin comprising peptides with the a risk for getting a major adverse cardiac event or death, wherein an elevated level is predictive for an enhanced risk of getting a major adverse cardiac event or death.
Dependencies are inferred from the claim text.